Neural Concept Accelerates Integrated AI Adoption With 100% Enterprise Growth
29.9.2025 09:00:00 CEST | Business Wire | Press Release
Neural Concept, the leading AI-first engineering environment for product development, today reported significant acceleration in customer growth and platform adoption so far in 2025. Following strong demand, the company is scaling its teams across Europe, North America and Asia.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250926074655/en/
Neural Concept's Design Lab: a native co-pilot experience where engineers and designers collaborate, bringing real-time physics into the design environment.
Enterprise adoption of Neural Concept's platform has doubled since January 2025, supported by a 40% increase in upsells as clients expanded from bespoke applications to company-wide use. Customers who have scaled their use of Neural Concept this year include Renault, Leonardo, GE Vernova U.S., Hanwha Ocean, Sumitomo Wiring Systems, SPAL Automotive, Kautex, Multi-Wing and more.
Annual recurring revenue (ARR) growth now significantly outpaces burn rate, placing the Company among the most capital-efficient performers in its sector. To meet ongoing demand, operations are scaling in Switzerland, France, Germany, North America, Japan, South Korea, and India.
Embedding AI at the Core: Development in Days, Not Months
Nearly half of Neural Concept’s customers are in automotive, where it has established market leadership, while rapidly acquiring clients in aerospace, defense, consumer electronics, and semiconductors, industries where innovation, performance, and sustainable design are critical.
“Engineering Intelligence is at a turning point—this technology is now powerful enough to deliver game-changing impact for customers at scale,” said Dr Pierre Baqué, CEO and co-founder of Neural Concept. “Industrial companies embracing this shift reach unprecedented performance levels in a fraction of the time-to-market. We help OEMs deploy AI-native workflows across design and simulation teams with a scalable toolbox and adaptable environment, enabling AI integration across the full product lifecycle without years-long integration or custom R&D.”
The platform’s impact is visible in high-performance engineering outcomes, boosting speed, accuracy, and accelerating innovation.
- General Motors developed an AI-powered crash safety model using Neural Concept that brings rapid risk prediction into the design process, enabling faster design iteration, greater collaboration and ultimately, safer vehicles.
- MAHLE announced a radically new bionic blower for automotive air conditioning systems by embedding Neural Concept’s AI into their existing systems, achieving 15% more efficiency and 4 dB less noise - ideal for EV platforms.
Strengthening Leadership and Expertise
Neural Concept has made strategic hires and formed an expert advisory board. Tom Becker, former Covariant GM, has joined the Company as SVP of Global Revenue, bringing his experience in AI robotics transformation and enterprise go-to-market strategy at Alteryx and KNIME.
The company's advisory board now includes:
- Brett Chouinard – Former Chief Product and Strategy Officer and Chief Technology Officer at Altair.
- François Fleuret – LLM Research Scientist at Meta and Professor of Computer Science at the University of Geneva.
- Jean-Paul Roux – Former Senior Vice President at EXA Corporation and VP of Sales at Dassault Systèmes.
- Florent Perrichon – Chairman of Neural Concept, Business Angel in Deep Tech and CEO of Laurent Ferrier.
VC-Backed Growth: Powering Enterprise Super Engineers
Following its Series B in 2024 — led by Forestay Capital and supported by D. E. Shaw Ventures — Neural Concept continues strong commercial traction, efficient growth, and an expanding strategic customer base.
“Neural Concept’s adoption growth shows both market demand and the team’s disciplined execution,” said Deborah Pittet, Partner at Forestay Capital. “They’re scaling with customer needs to achieve acceleration without over-extension. By embedding AI natively into engineering workflows, Neural Concept empowers global OEMs to own their AI transformation, making this growth sustainable and industry-defining.”
“We’re excited to partner with Neural Concept as they scale their engineering intelligence platform globally,” said Jazmin Medina, Investment Partner at D. E. Shaw Ventures. “By integrating AI seamlessly across hardware, software, and simulation, they’re tackling one of the most persistent challenges in product development — reducing time-to-market while maintaining quality and performance. In doing so, we believe they’re delivering the kind of world-class solutions that can transform how industries innovate.”
“Our platform isn’t a bolt-on, it’s a build-with,” concludes Dr Baqué. “We collaborate with engineering teams to cut design and development time from months to days, enabling faster innovation. More than a tool, we’re creating the engineering intelligence layer for the world’s most advanced companies. Our focus remains empowering engineers to lead the AI transformation of their industries, with full control over designing the future.”
About Neural Concept
Founded in 2018, Neural Concept provides the leading AI-first engineering platform for product development. By embedding AI natively into design and simulation workflows, Neural Concept empowers engineering teams to compress development cycles from months to days, improve product performance across efficiency, safety, and sustainability, and scale AI adoption without costly, years-long integration.
The company partners with more than 70% of the world’s largest OEMs and 40% of the top 100 tier-1 suppliers across automotive, aerospace, defense, consumer electronics, and semiconductors. Neural Concept was spun out of the Swiss Federal Institute of Technology in Lausanne (EPFL) and is backed by global investors, including Forestay Capital and D. E. Shaw Ventures.
For more information, visit www.neuralconcept.com.
Watch Neural Concept’s Design Lab for Engineering Intelligence in action — LINK
View source version on businesswire.com: https://www.businesswire.com/news/home/20250926074655/en/
Contacts
Media contact
ThoughtLDR for Neural Concept
neuralconcept@thoughtldr.com
+44 (0)7553600128
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom